Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 May 22;38(20):e185.
doi: 10.3346/jkms.2023.38.e185.

Immune Responses and Breakthrough Infections After COVID-19 Vaccination

Ki Tae Kwon  1
Affiliations
Editorial

Immune Responses and Breakthrough Infections After COVID-19 Vaccination

Ki Tae Kwon. J Korean Med Sci. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author has no potential conflicts of interest to disclose.

Comment on

References

    1. Park WB, Hwang YH, Cheong HJ. COVID-19 vaccination in Korea. Infect Chemother. 2023;55(1):135–149. - PMC - PubMed
    1. Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, et al. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant. N Engl J Med. 2022;386(16):1532–1546. - PMC - PubMed
    1. Kang YM, Minn D, Lim J, Lee KD, Jo DH, Choe KW, et al. Comparison of antibody response elicited by ChAdOx1 and BNT162b2 COVID-19 vaccine. J Korean Med Sci. 2021;36(46):e311. - PMC - PubMed
    1. Choi SH, Park JY, Kweon OJ, Park JH, Kim MC, Lim Y, et al. Immune responses after vaccination with primary 2-dose ChAdOx1 plus a booster of BNT162b2 or vaccination with primary 2-dose BNT162b2 plus a booster of BNT162b2 and the occurrence of omicron breakthrough infection. J Korean Med Sci. 2023;38(20):e155 - PMC - PubMed
    1. Wherry EJ, Barouch DH. T cell immunity to COVID-19 vaccines. Science. 2022;377(6608):821–822. - PubMed